Articles:
Publications:

2 hours ago

Ebola treatment trial begins in Congo as outbreak continues to grow

Ebola treatment trial begins in Congo as outbreak continues to grow

A trial for an experimental Ebola treatment has started in Congo, where the largest-ever Ebola outbreak continues to grow. Researchers begun the study of two possible treatments on Thursday at the Ebola treatment centre inside Bunia's Evangelical... Read more.

More on this topic

Turn on Transparency.
Ebola treatment trial begins in Congo as outbreak continues to grow
Owner: Australian Government More info
TASS 4 hours ago
Turn on Transparency.
Ebola death toll in DR Congo exceeds 490 — authorities
Owner: Russian Government More info
KETV 7 - Nebraska 3 hours ago
Turn on Transparency.
Residents in Congo cling to hope as a new Ebola treatment trial begins
Owner: Hearst Family through Hearst Communications More info
More

More from ABC (Australian Broadcasting Corporation)

Turn on Transparency.
Live: Piastri starts British GP eighth after driving 'nervous' McLaren
Owner: Australian Government More info
Turn on Transparency.
Ebola treatment trial begins in Congo as outbreak continues to grow
Owner: Australian Government More info
Turn on Transparency.
Trump marks US 250 with campaign-style July 4 speech after storms delay event
Owner: Australian Government More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

Jul. 3, 2026
What Is Happening to Climate Journalism?
Neutral | Owner: President & Fellows of Harvard College
Jul. 3, 2026
Brazil's Comics Journalism Is Growing Into a Bigger Speech Bubble
Center-left | Owner: The University of Texas at Austin

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more